Page last updated: 2024-08-24

triazoles and Communicable Diseases, Emerging

triazoles has been researched along with Communicable Diseases, Emerging in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L	1
Byrnes, E; Datta, K; Garcia-Effron, G; Marr, KA; Perlin, DS; Rhee, P; Staab, JF	1
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F	1
Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A	1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G	1
Jarque, I; Salavert, M	1
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S	1
Guarro, J; Pastor, FJ	1

Reviews

2 review(s) available for triazoles and Communicable Diseases, Emerging

Article	Year
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11 Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole	2011
[The role of voriconazole in the treatment of emerging mycoses]. Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2007

Article

Year

Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011

[The role of voriconazole in the treatment of emerging mycoses].

Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007

Other Studies

6 other study(ies) available for triazoles and Communicable Diseases, Emerging

Article	Year
Excavated pneumonia: an unusual suspect. Intensive care medicine, 2013, Volume: 39, Issue:7 Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole	2013
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility. Journal of clinical microbiology, 2013, Volume: 51, Issue:9 Topics: Antifungal Agents; Aspergillus; Azoles; Communicable Diseases, Emerging; Cryptococcus gattii; Humans; Microbial Sensitivity Tests; Mycoses; Neosartorya; Nitriles; North America; Pyridines; Triazoles	2013
[Rhodotorula glutinis sepsis. A case report]. Le infezioni in medicina, 2010, Volume: 18, Issue:2 Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole	2010
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica, 2005, Volume: 90 Suppl Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole	2005
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis	2006
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole	2006